Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1518663Generated: October 27, 2026

Sodium hydride → chloromethyl 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinoline-1(2H)-carboxylate

https://huagongshe.com/reaction/1518663

Reaction equation

Participants

RoleNameHCIDCharge
ReactantSodium hydrideHCID 24758—
ReactantAripiprazoleHCID 60795—
ReactantChloromethyl chloroformateHCID 62754—
Solvent2-MethyltetrahydrofuranHCID 7301—
SolventEthyl AcetateHCID 8857—
Productchloromethyl 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinoline-1(2H)-carboxylateHCID 66810238—

Reaction Conditions

Temperature0 °C

Reaction Steps

To a suspension of aripiprazole (2 g, 4.46 mmol) in 2-methyltetrahydrofuran (40 mL) was added NaH (357 mg, 8.92 mmol). After 20 minutes, further 2-methyltetrahydrofuran (20 mL) was added to aid stirring. Chloromethyl chloroformate (1.19 mL, 13.38 mmol) was then added and the reaction stirred for 2 days. The reactions were combined for work up. The reaction was cooled to 0° C., diluted with ethyl acetate (50 mL) and quenched with aqueous saturated NaHCO3 solution (50 mL). The reaction was extracted with ethyl acetate (3×50 mL) and the combined organics washed with brine (100 mL), then dried (MgSO4) and concentrated to give chloromethyl 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinoline-1(2H)-carboxylate (crude yield 2.59 g) as 3:2 mixture of product/aripiprazole. The product was not purified due to instability during silica chromatography and so taken onto the next step crude.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09072788B2
Source datasetuspto-grants-2015_07
ORD IDord-74036e2b1a8a4d01aaf97e84ba7d09b4
Source noteuspto-grants-2015_07